Psilocybin Maintains Better Brain Function in an Alzheimer’s Disease Model with Reduced Neuroinflammation and Improved Hippocampal Neurogenesis
Psilocybin treatment can maintain better brain function in an AD model without affecting amyloid-beta plaques. Improved brain function is likely due to psilocybin-induced reductions in neuroinflammatory signaling, enhanced hippocampal neurogenesis, and preservation of synapses.
Authors
- Jay S. Patel (ORCID: https://orcid.org/0000-0003-0559-5958)
- Prashanta Kumar Panda (ORCID: https://orcid.org/0000-0001-6223-8071)
- V. Seetharama Rao
- Sahithi Attaluri
- Maheedhar Kodali (ORCID: https://orcid.org/0000-0003-0741-4401)
- Xiaolan Rao
- ST Weintraub
- Shama Rao
- Yogish Somayaji (ORCID: https://orcid.org/0000-0002-8946-1633)
- Leelavathi N. Madhu
- Sanya Kotian
- Ashok K Shetty
- Bing Shuai
- Goutham Shankar
Institutions
- The University of Texas at San Antonio Health Science Center (US)
- California Institute for Regenerative Medicine (US)
- Urology San Antonio (US)
- Texas A&M Health Science Center (US)
- Texas A&M University (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70859_100589
- Primary Topic
- Psychedelics and Drug Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00